This trial is evaluating whether Aromatherapy with Essential Oils and Virtual Reality will improve 1 primary outcome and 1 secondary outcome in patients with Prognostic Stage IIA Breast Cancer AJCC v8. Measurement will happen over the course of Baseline/Day 1.
This trial requires 25 total participants across 1 different treatment group
This trial involves a single treatment. Aromatherapy With Essential Oils And Virtual Reality is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"Results from a recent clinical trial suggest that both genetic predisposition and environmental factors may play a role in the development of breast cancer in certain families. The increased risk of breast cancer associated with family history, especially in young-onset cases, warrants further investigation from a genetic perspective." - Anonymous Online Contributor
"The incidence of breast cancer increases with age. Women ≤40 years have higher incidence rates of breast cancer than women ≥ 50 years. Mammography screening should begin at age 40 years." - Anonymous Online Contributor
"There are many different treatments for [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer) including surgery, radiation therapy, chemotherapy and hormonal therapy. The best treatment depends on the type of cancer and other factors such as age. When breast cancer is detected early, then before any symptoms appear, it can often be treated with surgery alone. Chemotherapy may also be used, but usually after surgery. Radiotherapy is sometimes used after surgery to help destroy remaining cancer cells. If breast cancer is found late, then specific drugs used in chemotherapy may be given. In some cases, hormonal therapy may be prescribed instead of chemotherapy. Hormonal therapy can reduce swelling and pain associated with breast cancer, but does not work against the cancer itself." - Anonymous Online Contributor
"The conclusions from this study suggest that aromatherapy may have a role as an adjuvant therapy for breast cancer patients who undergo surgery. Further studies should be conducted to determine whether and how such an intervention influences quality of life and disease free survival." - Anonymous Online Contributor
"Based on the data, the typical woman is at least 1% to 2% likely to develop breast cancer by age 50. If she is a survivor of breast cancer, then the risk of subsequent development of breast cancer is up to 25% after 10 years. This indicates that it is important to look into the possibility of breast cancer unless there are strong indications against doing so. There is no indication that screening recommendations need to be changed. Breast cancer is a very dangerous disease with poor prognosis. Screening mammography will never be cost effective, but it is essential to collect information on family history of breast cancer--especially if the family history does not include any first degree relatives who have had breast cancer." - Anonymous Online Contributor
"Data from a recent study suggest that aromatherapy with essential oils may reduce anxiety and pain during BCT, but no significant difference was found between the study groups in terms of treatment outcome. Data from a recent study of our study show that aromatherapy with essential oils and virtual reality may help decrease pain and anxiety in patients undergoing irradiation. Future investigations will focus on decreasing discomfort caused by ultrashort bursts of intense electromagnetic radiation in addition to the use of aromatherapy and virtual reality." - Anonymous Online Contributor
"Survival rates vary widely between different geographic areas. Although survival varies by race and ethnicity, overall survival is highest among women with tumors of smallest size, early stage, and hormone receptor positive status." - Anonymous Online Contributor
"Multifactorial aromatherapy has demonstrated significant effects in improving QoL scores for women with nonmetastatic breast cancer. This multifactorial intervention may also improve women's perceptions of their QoL. As such, this approach merits further consideration as a method of improving QoL for women with breast cancer." - Anonymous Online Contributor
"Breast cancer is a complex disease involving multiple genetic, epigenetic and environmental factors. The underlying mechanism of breast cancer involves interactions between tumor suppressor genes and oncogenes. The key aspects of breast cancer are that it occurs mainly in post-menopausal women who have had at least one child; usually in women aged 40 to 60 years; and it may be triggered by hormones produced during pregnancy and puberty. The risk of breast cancer increases if additional pregnancies occur before 30 years of age. Many factors influence the likelihood of getting breast cancer later in life such as family history, estrogen receptor status, and the amount of circulating estrogens. The development of breast cancer requires an accumulation of multiple alterations in gene expression and epigenetics." - Anonymous Online Contributor
"Although the primary cause of breast cancer remains unclear, we found compelling evidence that breast cancer can result from a combination of factors. This means that prevention is not just based on reducing exposure to environmental risk factors. Rather, the reduction of environmental exposures should be accompanied by strategies aimed at reducing the burden of lifetime exposures to environmental factors that increase the likelihood of breast cancer." - Anonymous Online Contributor
"Because of the limited availability of clinical trials, we can only conclude that aromatherapy may be beneficial in both the short term and long term. Although EOs may have a small effect on symptoms in the short term, they appear to provide additional benefits when combined with other forms of treatment, particularly psychological. Further studies are needed to determine if aromatherapy combinations will lead to improved outcomes." - Anonymous Online Contributor